V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression

Cancer Research

Volumn 57, Issue 23, 1997, Pages 5328-5335

  Jiang, Bing Hua ^a   Agani, Faton ^a   Passaniti, Antonino ^b   Semenza, Gregg L ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOLASE; VASCULOTROPIN;

ADAPTATION; ANIMAL CELL; ARTICLE; DNA BINDING; GENE INDUCTION; GENETIC TRANSCRIPTION; GLYCOLYSIS; HYPOXIA; MICROCIRCULATION; MOUSE; NONHUMAN; ONCOGENE SRC; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR XENOGRAFT;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CELL LINE; CLONE CELLS; DISEASE PROGRESSION; DNA-BINDING PROTEINS; EMBRYO; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER NEOPLASMS, EXPERIMENTAL; LYMPHOKINES; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; OLIGODEOXYRIBONUCLEOTIDES; ONCOGENE PROTEIN PP60(V-SRC); PHOSPHOPYRUVATE HYDRATASE; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RATS; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030659531     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid, and other disease. Nat. Med., 1: 27-31, 1995.
2. Fox, S. B. Tumor angiogenesis and prognosis. Histopathology, 30: 294-301, 1997.
3. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (Lond.), 380: 435-439, 1996.
4. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell Braxton, L., Hillan, K. J., and Moore, M. W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (Lond.), 380: 439-442, 1996.
5. Borgstrom, P., Killan, K. J., Sriramarao, P., and Ferrara, N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital video microscopy. Cancer Res., 56: 4032-4039, 1996.
6. Cheng, S-Y., Huang, H-J. S., Nagane, M., Ji, X-D., Wang, D., Shih, C. C-Y., Arap, W., Huang, C-M., and Cavenee, W. K. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA, 93: 8502-8507, 1996.
7. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.), 362: 841-844, 1993.
8. Saleh, M., Stacker, S. A., and Wilks, A. F. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res., 56: 393-401, 1996.
9. Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., and Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest., 95: 1789-1797, 1995.
10. Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., and Jain, R. K. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. USA, 93: 14765-14770, 1996.
11. Plate, K. H., Breier, G., Millauer, B., Ullrich, A., and Risau, W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res., 53: 5822-5827, 1993.
12. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
13. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
14. Shweiki, D., Neeman, M., Itin, A., and Keshet, E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc. Natl. Acad. Sci. USA, 92: 768-772, 1995.
15. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med., 3: 177-182, 1997.
16. Vaupel, P., Kallinowski, F., and Okunieff, P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res., 49: 6449-6465, 1989.
17. Robin, E. D., Murphy, B. J., and Theodore, J. Coordinate regulation of glycolysis by hypoxia in mammalian cells. J. Cell. Physiol., 118: 287-290, 1984.
18. Webster, K. A., Gunning, P., Hardeman, E., Wallace, D. C., and Kedes, L. Coordinate reciprocal trends in glycolytic and mitochondrial transcript accumulations during the in vitro differentiation of human myoblasts. J. Cell. Physiol., 142: 566-573, 1990.
19. Younes, M., Lechago, L. V., Somoano, J. R., Mosharaf, M., and Lechago, J. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res., 56: 1164-1167, 1996.
20. Warburg, O. On respiratory impairment in cancer cells. Science (Washington DC), 124: 269-270, 1956.
21. Semenza, G. L., Jiang, B-H., Leung, S. W., Passantino, R., Concordet, J-P., Maire, P., and Giallongo, A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxiainducible factor 1. J. Biol. Chem., 271: 32529-32537, 1996.
22. Semenza, G. L., Roth, P. H., Fang, H-M., and Wang, G. L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem., 269: 23757-23763, 1994.
23. Hockel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U., and Vaupel, P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res., 56: 4509-4515, 1996.
24. Brizel, D. M., Scully, S. P., Harrelson, J. M., Layfield, L. J., Bean, J. M., Prosnitz, L. R., and Dewhirst, M. W. Tumor oxygenation predicts the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res., 56: 941-943, 1996.
25. Schwickert, G., Walenta, S., Sundfor, K., Rofstad, E. K., and Mueller-Klieser, W. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res., 55: 4757-4759, 1995.
26. Ikeda, E., Achen, M. G., Breier, G., and Risau, W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem., 270: 19761-19766, 1995.
27. Levy, A. P., Levy, N. S., Wegner, S., and Goldberg, M. A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem., 270: 13333-13340, 1995.
28. Webster, K. A. Regulation of glycolytic enzyme RNA transcriptional rates by oxygen availability in skeletal muscle cells. Mol. Cell. Biochem., 77: 19-28, 1987.
29. Ebert, B. L., Firth, J. D., and Ratcliffe, P. J. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences. J. Biol. Chem., 270: 29083-29089, 1995.
30. Firth, J. D., Ebert, B. L., Pugh, C. W., and Ratcliffe, P. J. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc. Natl. Acad. Sci. USA, 91: 6496-6500, 1994.
31. Firth, J. D., Ebert, B. L., and Ratcliffe, P. J. Hypoxic regulation of lactate dehydrogenase A: interaction between hypoxia-inducible factor 1 and cAMP response elements. J. Biol. Chem., 270: 21021-21027, 1995.
32. Forsythe, J. A., Jiang, B-H., Iyer, N. V., Agani, N., Leung, S. W., Koos, R. D., and Semenza, G. L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol., 16: 4604-4613, 1996.
33. Li, H., Ko, H. P., and Whitlock, J. P., Jr. Induction of phosphoglycerate kinase 1 gene expression by hypoxia: roles of ARNT and HIF-1α. J. Biol. Chem., 271: 21262-21267, 1996.
34. Salceda, S., Beck, I., and Caro, J. Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia. Arch. Biochem. Biophys., 334: 389-394, 1996.
35. Wood, S. M., Gleadle, J. M., Pugh, C. W., Hankinson, O., and Ratcliffe, P. J. The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression: studies in ARNT-deficient cells. J. Biol. Chem., 271: 15117-15123, 1996.
36. 2 tension. Proc. Natl. Acad. Sci. USA, 92: 5510-5514, 1995.
37. Hoffman, E. C., Reyes, H., Chu, F-F., Sander, F., Conley, L. H., Brooks, B. A., and Hankinson, O. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science (Washington DC), 252: 954-958, 1991.
38. 2 tension. Am. J. Physiol., 271: C1172-C1180, 1996.
39. Wang, G. L., and Semenza, G. L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA, 90: 4304-4308, 1993.
40. Wenger, R. H., Rolfs, A., Marti, H. H., Guenet, J-L., and Gassmann, M. Nucleotide sequence, chromosomal assignment and mRNA expression of mouse hypoxia-inducible factor 1α. Biochem. Biophys. Res. Commun., 223: 54-59, 1996.
41. Wiener, C. M., Booth, G., and Semenza, G. L. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun., 225: 485-488, 1996.
42. Huang, L. E., Arany, Z., Livingston, D. M., and Bunn, H. F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit. J. Biol. Chem., 271: 32253-32259, 1996.
43. Jiang, B-H., Rue, E., Wang, G. L., Roe, R., and Semenza, G. L. Dimerization, DNA-binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem., 271: 17771-17778, 1996.
44. Jiang, B-H., Zheng, J. Z., Leung, S. W., Roe, R., and Semenza, G. L. Transactivation and inhibitory domains of hypoxia-inducible factor 1α: modulation of transcriptional activity by oxygen tension. J. Biol. Chem., 272: 19253-19260, 1997.
45. Dachs, G. U., Patterson, A. V., Firth, J. D., Ratcliffe, P. J., Townsend, K. M. S., Stratford, I. J., and Harris, A. L. Targeting gene expression to hypoxic tumor cells. Nat. Med., 3: 515-520, 1997.
46. Mukhopadhyay, D., Tsiokas, L., Zhou, X-M., Foster, D., Brugge, J. S., and Sukhatme, V. P. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature (Lond.), 375: 577-581, 1995.
47. Mukhopadhyay, D., Tsiokas, L., and Sukhatme, V. P. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res., 55: 6161-6165, 1995.
48. Semenza, G. L., and Wang, G. L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol., 12: 5447-5454, 1992.
49. Wang, G. L., and Semenza, G. L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem., 270: 1230-1237, 1995.
50. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
51. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
52. Maroney, A. C., Qureshi, S. A., Foster, D. A., and Brugge, J. S. Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells. Oncogene, 7: 1207-1214, 1992.
53. Dang, C. V., Barrett, J., Villa-Garcia, M., Resar, L. M. S., Kato, G. J., and Fearon, E. R. Intracellular leucine zipper interactions suggest c-myc hetero-oligomerization. Mol. Cell. Biol., 11: 954-962, 1991.
54. 2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev., 8: 2527-2539, 1994.
55. Soriano, P., Montgomery, C., Geske, R., and Bradley, A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell, 64: 693-702, 1991.
56. Gleadle, J. M., and Ratcliffe, P. J. Induction of hypoxia-inducible factor 1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase. Blood, 89: 503-509, 1997.
57. Gopalbhai, K., and Meloche, S. Repression of MAP kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins. J. Cell. Physiol., in press, 1997.
58. Levy, A. P., Levy, N. S., and Goldberg, M. A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem., 271: 2746-2753, 1996.
59. Stein, I., Neeman, M., Shweiki, D., Itin, A., and Keshet, E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol., 15: 5363-5368, 1995.
60. Wang, G. L., Jiang, B-H., and Semenza, G. L. Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun., 216: 669-675, 1995.
61. Carroll, R. C., Ash, J. F., Vogt, P. K., and Singer, S. J. Reversion of transformed glycolysis to normal by inhibition of protein synthesis in rat kidney cells infected with temperature-sensitive mutant of Rous sarcoma virus. Proc. Natl. Acad. Sci. USA, 75: 5015-5019, 1978.
62. Singh, V. N., Singh, M., August, J. T., and Horecker, B. L. Alterations in glucose metabolism in chick-embryo cells transformed by Rous sarcoma virus: intracellular levels of glycolytic intermediates. Proc. Natl. Acad. Sci. USA, 71: 4129-4132, 1974.
63. Steck, T. L., Kaufman, S., and Bader, J. P. Glycolysis in chick embryo cell cultures transformed by Rous sarcoma virus. Cancer Res., 28: 1611-1619, 1968.
64. Shim, H., Dolde, C., Lewis, B. C., Wu, C-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., and Dang, C. V. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA, 94: 6658-6663, 1997.
65. Mazure, N. M., Chen, E. Y., Yen, P., Laderoute, K. R., and Giaccia, A. J. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res., 56: 3436-3440, 1996.
66. Arbiser, J. L., Moses, M. A., Fernandez, C. A., Ghiso, N., Cao, Y., Klauber, N., Frank, D., Brownlee, M., Flynn, E., Parangi, S., Byers, H. R., and Folkman, J. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc. Natl. Acad. Sci. USA, 94: 861-866, 1997.
67. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature (Lond.), 379: 88-91, 1996.
68. Rempel, A., Mathupala, S. P., Griffin, C. A., Hawkins, A. L., and Pedersen, P. L. Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase. Cancer Res., 56: 2468-2471, 1996.
69. Gnarra, J. R., Zhou, S., Merrill, M. J., Wagner, J. R., Krumm, A., Papavassiliou, E., Oldfield, E. H., Klausner, R. D., and Linehan, W. M. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl. Acad. Sci. USA, 93: 10589-10594, 1996.
70. Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., Jr., and Goldberg, M. A. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA, 93: 10595-10599, 1996.
71. Semenza, G. L. Transcriptional regulation by hypoxia-inducible factor 1: molecular mechanisms of oxygen homeostasis. Trends Cardiovasc. Med., 6: 151-157, 1996.